Danny N. Khalil, MD, PhD - MSK Gastrointestinal Oncologist & Early Drug Development Specialist

Gastrointestinal oncology goes beyond basic scanning. Early drug development calls for a sharp eye and specialized tools. When cancer in the digestive system needs precision, patients often look for specialists fluent in both oncology and research. Danny N. Khalil, MD, PhD bridges those two worlds, practicing as a gastroenterologist focused on tumors of the GI tract while probing new therapies in clinical trials. The setting speaks to the neighborhood’s broader medical depth— just a few blocks from major cancer centers in Midtown Manhattan.

Board-certified in internal medicine and hematology/oncology, the physician designs programs blending routine monitoring with targeted interventions for complex cases. Rapid access to diagnostic imaging—including endoscopic ultrasound, CEA blood tests, and CT/PET scans—helps streamline each step. Targeted biopsies, immunotherapy options, and liver-directed treatments round out the clinical toolbox. Across Manhattan and the surrounding boroughs, referrals for unusual GI cancers often land here.

The office sits at 160 E 53rd St, New York, NY 10022, a stretch where medical specialty feeds into supportive care infrastructure. Neighboring hospitals and labs allow seamless coordination when extra layers of testing or hospital stays are needed. Some visitors arrive by bridge from Queens, others by subway from Brooklyn; everyone shares one goal—to reach the right specialist before the disease advances.

Need the fastest route? A quick scan of the map will show the quickest lanes or drop-pin the accurate elevator bank. Call (347) 798-8511 to confirm timing or clarify insurance coordination.